Conceptio
›
Archive
›
ClinicalTrials.gov
ClinicalTrials.gov
public full text
GSL Synthetase Inhibitor Eliglustat Combined With CD30 Target Immunotherapy for the Treatment of of CD30+ Lymphoma
Chinese PLA General Hospital
· 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
lymphoma, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia(CIT) in Patients With Acute Myeloid Leukemia
#887368
Deferment of Imaging for Pulmonary Embolism
#887360
36 Versus 42 Hour Time Interval From Ovulation to Intrauterine Insemination
#887364
How Should Surgical Residents Be Educated About Patient Safety
#887366
The Effects of the Oral Nutritional Supplement With β-hydroxy-β-methylbutyrate in Lean Body Mass Among Taiwan Elderly
#887367
Record
· ID 856261
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.